Shionogi forms JV with Ping An to expand in China and targets immuno-oncology for next venture

Japanese infectious disease specialist Shionogi & Co. Ltd. said it will partner with Chinese insurance giant Ping An to establish a data-driven joint venture to develop new drugs in a deal involving ¥‎33.53 billion (US$311 million. <ClickHere>